GetTopicDetailResponse(id=59ed5084328, topicName=德拉馬尼, introduction=德拉馬尼, content=null, image=null, comments=3, allHits=1230, url=https://h5.medsci.cn/topic?id=50843, type=0, isShow=1, status=1, isAdmin=null, adminId=1, adminEncryptionId=1eae1, adminName=小M, createdBy=null, createdName=, createdAvatar=, createdTime=Fri May 29 21:19:53 CST 2020, time=2020-05-29, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=101968, tagList=[TagDto(tagId=101968, tagName=德拉馬尼)], ipAttribution=, topicAdmin=1, lengthMark=0)
[GetTopicListResponse(id=2250480, encodeId=a8eb225048014, content=<a href='/topic/show?id=391de865327' target=_blank style='color:#2F92EE;'>#結(jié)核病#</a> <a href='/topic/show?id=2f363232442' target=_blank style='color:#2F92EE;'>#利福平#</a> <a href='/topic/show?id=f09732281ed' target=_blank style='color:#2F92EE;'>#利奈唑胺#</a> <a href='/topic/show?id=6b1b8e9908a' target=_blank style='color:#2F92EE;'>#莫西沙星#</a> <a href='/topic/show?id=0a4e9223ee3' target=_blank style='color:#2F92EE;'>#貝達(dá)喹啉#</a> <a href='/topic/show?id=59ed5084328' target=_blank style='color:#2F92EE;'>#德拉馬尼#</a>, objectTitle=NEJM：利福平耐藥、氟喹諾酮敏感結(jié)核病的口服治療方案（endTB 試驗(yàn)）, objectType=article, longId=861986, objectId=a1d1861986b5, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20250203/1738653528901_4754896.jpg, objectUrl=/article/show_article.do?id=a1d1861986b5, replyNumber=1, likeNumber=40, createdTime=2025-02-04, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=威斯康星, moduleDTOList=[ModuleDTO(moduleId=a1d1861986b5, moduleTitle=NEJM：利福平耐藥、氟喹諾酮敏感結(jié)核病的口服治療方案（endTB 試驗(yàn)）, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=a1d1861986b5)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=1969835, encodeId=06b5196983506, content=<a href='/topic/show?id=59ed5084328' target=_blank style='color:#2F92EE;'>#德拉馬尼#</a>, objectTitle=Clin Infect Dis：接受貝達(dá)喹啉或德拉馬尼治療的耐藥結(jié)核病患者的臨床結(jié)局, objectType=article, longId=192313, objectId=2b2a192313d4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2b2a192313d4, replyNumber=0, likeNumber=107, createdTime=2020-06-23, rootId=0, userName=baoya, userId=743d308, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2b2a192313d4, moduleTitle=Clin Infect Dis：接受貝達(dá)喹啉或德拉馬尼治療的耐藥結(jié)核病患者的臨床結(jié)局, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=2b2a192313d4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1969834, encodeId=9580196983462, content=<a href='/topic/show?id=59ed5084328' target=_blank style='color:#2F92EE;'>#德拉馬尼#</a>, objectTitle=【匯總】貝達(dá)喹啉聯(lián)合德拉馬尼治療耐藥性肺結(jié)核的療效及安全性分析, objectType=article, longId=192282, objectId=70fc1922828e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=70fc1922828e, replyNumber=0, likeNumber=0, createdTime=2021-03-14, rootId=0, userName=baoya, userId=743d308, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=70fc1922828e, moduleTitle=【匯總】貝達(dá)喹啉聯(lián)合德拉馬尼治療耐藥性肺結(jié)核的療效及安全性分析, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=70fc1922828e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1969833, encodeId=a9d0196983309, content=<a href='/topic/show?id=59ed5084328' target=_blank style='color:#2F92EE;'>#德拉馬尼#</a>, objectTitle=含德拉馬尼治療方案在成人和兒童（≥6歲）耐藥結(jié)核病患者中的“同情用藥”, objectType=article, longId=190635, objectId=0f5b19063503, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0f5b19063503, replyNumber=0, likeNumber=106, createdTime=2020-09-29, rootId=0, userName=baoya, userId=743d308, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0f5b19063503, moduleTitle=含德拉馬尼治療方案在成人和兒童（≥6歲）耐藥結(jié)核病患者中的“同情用藥”, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=0f5b19063503)], followStatus=false, userIsMember=false, type=1, lengthMark=0)]
梅斯話題小助手
2020-05-29
